Jieyou F. Zhang

Key Laboratory Of Breast Cancer Prevention And Therapy, Key Laboratory Of Immune Microenvironment And Disease, State Key Laboratory Of Experimental Hematology
Tianjin, 300070, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

RNA exonuclease REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity.

RNA exonuclease REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity.

Journal: Molecular cell
Published: February 20, 2025

Relationship between blood uric acid levels and body composition in patients with polycystic ovary syndrome

Relationship between blood uric acid levels and body composition in patients with polycystic ovary syndrome

Journal: Zhonghua fu chan ke za zhi
Published: July 20, 2023

ADAR1 links R-loop homeostasis to ATR activation in replication stress response.

ADAR1 links R-loop homeostasis to ATR activation in replication stress response.

Journal: Nucleic acids research
Published: June 22, 2023

Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics.

Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics.

Journal: Cancer letters
Published: November 15, 2021

A PARylation-phosphorylation cascade promotes TOPBP1 loading and RPA-RAD51 exchange in homologous recombination.

A PARylation-phosphorylation cascade promotes TOPBP1 loading and RPA-RAD51 exchange in homologous recombination.

Journal: Molecular cell
Published: September 27, 2021

miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.

miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.

Journal: International immunopharmacology
Published: February 14, 2021

Arctigenin protects mice from thioglycollate-induced acute peritonitis.

Arctigenin protects mice from thioglycollate-induced acute peritonitis.

Journal: Pharmacology research & perspectives
Published: June 30, 2020

Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization.

Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization.

Journal: Nature communications
Published: June 05, 2020

Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity.

Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity.

Journal: Journal for immunotherapy of cancer
Published: April 09, 2020

Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment.

Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment.

Journal: Signal transduction and targeted therapy
Published: January 23, 2020

miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shock.

miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shock.

Journal: Cell death & disease
Published: April 18, 2019

Parthenolide regulates oxidative stress-induced mitophagy and suppresses apoptosis through p53 signaling pathway in C2C12 myoblasts.

Parthenolide regulates oxidative stress-induced mitophagy and suppresses apoptosis through p53 signaling pathway in C2C12 myoblasts.

Journal: Journal of cellular biochemistry
Published: November 20, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026